Effect of VSL#3 on Bone Mineral Density in Postmenopausal Women (ProBoneVSL)
Effect of VSL#3 on Bone Mineral Density in Postmenopausal Women: a Pilot Randomized, Placebo-Controlled Trial
Sponsor: Emory University
Terminated
Investigator terminated trial pursuant to research contract rights.
This PHASE2 trial investigates Menopausal Osteoporosis and is currently terminated or withdrawn. Emory University leads this study, which shows 12 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Jan 2023 — Jul 2024 [monthly]
Terminated PHASE2
-
Dec 2022 — Jan 2023 [monthly]
Terminated PHASE2
-
Jan 2021 — Dec 2022 [monthly]
Terminated PHASE2
▶ Show 7 earlier versions
-
Apr 2020 — Jan 2021 [monthly]
Terminated PHASE2
-
Apr 2019 — Apr 2020 [monthly]
Terminated PHASE2
Status: Active Not Recruiting → Terminated
-
Mar 2019 — Apr 2019 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Aug 2018 — Mar 2019 [monthly]
Recruiting PHASE2
-
Jun 2018 — Aug 2018 [monthly]
Recruiting PHASE2
-
Nov 2017 — Jun 2018 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Jun 2017 — Nov 2017 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Emory University
For direct contact, visit the study record on ClinicalTrials.gov .